Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $15.81 in the prior trading day, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $15.56, down -1.58%. In other words, the price has decreased by -$1.58 from its previous closing price. On the day, 1.16 million shares were traded. KALV stock price reached its highest trading level at $16.09 during the session, while it also had its lowest trading level at $15.53.
Ratios:
Our goal is to gain a better understanding of KALV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on January 31, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $19.
On January 07, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $30.
On December 18, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.BofA Securities initiated its Buy rating on December 18, 2024, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 09 ’25 when Palleiko Benjamin L sold 32,979 shares for $15.69 per share. The transaction valued at 517,523 led to the insider holds 369,595 shares of the business.
Yea Christopher sold 30,250 shares of KALV for $474,698 on Jul 09 ’25. The CHIEF DEVELOPMENT OFFICER now owns 127,939 shares after completing the transaction at $15.69 per share. On Jun 09 ’25, another insider, Palleiko Benjamin L, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 7,169 shares for $14.50 each. As a result, the insider received 103,950 and left with 315,074 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KALV now has a Market Capitalization of 789768064 and an Enterprise Value of 668852160.
Stock Price History:
The Beta on a monthly basis for KALV is 0.05, which has changed by 0.08130646 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, KALV has reached a high of $16.32, while it has fallen to a 52-week low of $7.30. The 50-Day Moving Average of the stock is 18.66%, while the 200-Day Moving Average is calculated to be 38.57%.
Shares Statistics:
The stock has traded on average 1.11M shares per day over the past 3-months and 1387740 shares per day over the last 10 days, according to various share statistics. A total of 49.76M shares are outstanding, with a floating share count of 38.59M. Insiders hold about 22.75% of the company’s shares, while institutions hold 88.01% stake in the company. Shares short for KALV as of 1751241600 were 8499323 with a Short Ratio of 7.68, compared to 1748563200 on 6221402. Therefore, it implies a Short% of Shares Outstanding of 8499323 and a Short% of Float of 19.299999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
